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saturation of key themes (Figure 1). Reliability and validity of
coding were assessed (kappa >.90). Patients/caregivers re-
ported challenges in accessing specialty care due to providers’
unfamiliarity with HCT and felt SCP should be more person-
alized with robust sections on psychosocial, sexual/mental
health, and nutrition/diet. Providers wanted the treatment
history to focus only onwhat theymust know to care for their
patient and found SCP markedly better than what they
currently receive. All preferred to receive SCP electronically;
however, hardcopywas still considered necessary for patients
without computer access. Both patients and providers iden-
tiﬁed that SCPwill facilitate appropriate post-HCTcare. Similar
themes were identiﬁed among the three health professional
groups, with the exception of screening and care for psycho-
social issues that was more frequently brought up by the
nurses/social workers. Our study highlights the need for a SCP
instrument to facilitate HCT survivorship care. Patient and
provider feedback has been used to develop a ﬁnal SCP that is
being tested in a randomized trial.219
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Background: In advanced cancers, patients’ prognostic per-
ceptions inﬂuence their medical decisions. However, little is
known about how patients with hematologic malignancies
undergoing hematopoietic stem cell transplantation (HCT)
and their family caregivers (FC) understand their prognosis.
We examined prognostic perception in these patients during
hospitalization for HCT and its relationship with QOL and
mood.Figure 1A.Methods: We conducted a longitudinal study of patients
(and FC) hospitalized for HCT. At baseline (6 days pre-HCT),
we used a 10-item questionnaire to measure patients’ and FC
information preferences, and perception of prognosis. Using
2 items, we also asked the treating oncologists regarding the
patients’ prognosis. At day-6, day+1, day+8 of HCT, we
assessed QOL (Functional Assessment of Cancer Therapy-
Bone Marrow Transplantation FACT-BMT), and mood
(Hospital Anxiety and Depression Scale). We examined the
relationship between patients’ prognostic perception and
their QOL and mood during hospitalization for HCT using
multivariable linear mixed models.
Results: We enrolled 97% of consecutively eligible patients
undergoing autologous (n¼30), myeloablative (n¼30) or
reduced intensity (n¼30) allogeneic HCT. Most patients (80/
90, 88.9%) and FC (41/47, 87.1%) believed that it is “extremely”
or “very” important to know about prognosis [Figure 1A].
However, the majority of patients (66/85, 77.6%) and FC (33/
46, 71.7%) reported an inaccurate and more optimistic
perception of the patients’ prognosis compared to the
oncologist (P’s < 0.0001) [Figure 1B]. Patients with accurate
prognostic understanding reported lower QOL (P ¼ 0.03)
and worse depressive symptoms (P ¼ 0.04) with a steeper
increase in depression (P ¼ 0.006) over time compared to
patients with an inaccurate optimistic prognostic perception.
Conclusions: The majority of patients and FC reported
inaccurate and more optimistic perception of prognosis
compared with the oncologist. Patients with an accurate
perception of their prognosis had lower QOL, higher
depression, and a steeper increase in depression during
hospitalization for HCT. Interventions are needed to improve
prognostic understanding while providing adequate psy-
chosocial support during HCT.220
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